baber/WOPTO huggingface dataset:
Patent DE-69126034-T2 (DE)
Inventor: BAECKERUD STIG LENNART
IPC: G01N33/20
Filed: 1991-10-11
Granted: 1997-08-14
Abstract: PCT No. PCT/SE91/00685 Sec. 371 Date Apr. 15, 1993 Sec. 102(e) Date Apr. 15, 1993 PCT Filed Oct. 11, 1991 PCT Pub. No. WO92/06809 PCT Pub. Date Apr. 30, 1992.A method relating to the production of cast iron castings with compacted graphite crystals. The method comprises controlling and correcting the composition of the cast iron melt and securing the necessary amount of structure modifying agent. A sample of the melt is taken with a sample vessel provided with two thermocouples, one positioned so as to be in the centre of the sample and the other positioned so as to be in the vicinity of the vessel wall. The vessel wall contains or is coated with a layer of a substance which will lower the concentration of dissolved elementary magnesium in the melt in the vicinity of the vessel wall by at least 0.0030%. The temperature/time values obtained through two temperature responsive means are recorded. The occurrence of a plateau temperature will provide information as to the precipitation of flaky graphite in the vicinity of the vessel wall, therewith enabling corrections to be made to the concentration of the modifying agent and to ensure the formation of compacted graphite crystal during the whole of the pouring time required in the foundry process concerned.
Patent DE-69126049-T2 (DE)
Inventor: GERLITZ BRUCE EDWARD
IPC: C12R1/19
Filed: 1991-02-22
Granted: 1997-09-25
Abstract: A method for the recombinant production of forms of human protein C with higher activity is described. These forms differ from native protein C in their increased amidolytic and functional activities and novel carbohydrate structures. DNA compounds, vectors, and transformants useful in the method are also disclosed.
Patent DE-69127445-T2 (DE)
Inventor: HUNTER ROBERT
IPC: A61K39/39
Filed: 1991-06-27
Granted: 1998-03-19
Abstract: The present invention comprises adjuvants which, when admixed with an antigen and administered into a human or animal, will induce a more intense immune response to the antigen than when the antigen is administered alone. In many cases, the adjuvant that is described as the present invention will increase overall titer of antibodies of a specific isotype which are specific for the antigen. For example, in mice, when the adjuvant of the present invention is admixed with a conventional antigen, the isotype that is induced in the mouse is changed from a predominantly IgG1 isotype to the more protective IgG2 isotype and, in some cases, IgG3 isotype. Thus, by practicing the present invention, one can improve the overall protective effect of conventional vaccines.
Patent DE-69220486-T2 (DE)
Inventor: BARFIELD MALCOLM RAYMOND
IPC: B29C48/10
Filed: 1992-04-24
Granted: 1997-10-16
Abstract: A tube for fluids is a substantially rigid structural composite of metal and plastics functioning together to provide the tube with strength to resist internal or external fluid pressures through a range of operating temperatures and, when required, with a heat exchange capacity. The metal forms a tubular core (15) having openings throughout its length occupying at least 5 % of its total surface area. The plastics material forms imperforate inner (24) and outer (25) layers, each at least 0.1 mm thick, covering the inside and outside of the metal core and integrally joined through the openings. The combined thickness of the plastics layers is substantially equal to or greater than the metal thickness. Preferably the metal is expanded and flattened sheet or strip. The inner plastics layer may be a pre-formed lining inside the core and the outer layer may be extruded onto the core to join through the openings to the inner layer. Preferably the plastics is extruded externally onto the core to form both layers.
Patent DE-69224684-T2 (DE)
Inventor: ULLAH ISMAT
IPC: A61K33/12
Filed: 1992-07-20
Granted: 1998-11-12
Abstract: Improved oral dosage formulations for acid-labile dideoxy purine nucleoside derivatives such as ddA, ddI, and ddG, have been developed by incorporating selected water-insoluble buffering systems in the formulation. These novel formulations provide reduced mass dosage units in the form of convenient, palatable chewable/ dispersible tablets or a dry powder sachet. The reduced mass requirement, necessary to allow tablets of reasonable size, was achieved in part by an unexpected 20 to 25% increase in drug bioavailability resulting from use of the selected buffering systems comprised of an insoluble magnesium antacid agent and either dihydroxyaluminum sodium carbonate or calcium carbonate.
Patent DE-69228614-T2 (DE)
Inventor: SVENDENIUS NILS
IPC: F21V7/09
Filed: 1992-12-07
Granted: 1999-09-30
Abstract: The invention concerns a reflector (1) for an electrical radiation fitting (31) as well as a radiation fitting provided with one or several such reflectors. A reflector comprises top sections (3, 4) and with respect to the longitudinal extension of the fitting longitudinal sections (5, 6). The interior side of the reflector is provided with a reflecting layer (2). According to the invention, to the top section (3, 4) and the longitudinal sections (5, 6) there are connected at an angle of app. 45 DEG  oblique diagonal sections (7-10) for controlling the light from a fluorescent tube (13) mainly in diagonal and longitudinal direction of the fitting. Between a pair of diagonal sections (7, 10) respectively (8, 9) there extends in transverse direction of the fitting transverse sections (11, 12), above which there are triangle-shaped openings for introduction of a fluorescent tube (13). The radiation fitting (31) is provided with a larger number of reflectors arranged in series, the lateral outer sides of which are situated within vertical planes for flush abutment against each other, the free edges of the sections being provided to rest upon a border (32) surrounding the fitting.
Patent DE-69229271-T2 (DE)
Inventor: ZIELINSKI RONALD
IPC: C08J7/12
Filed: 1992-07-16
Granted: 2000-01-05
Abstract: A method of producing fluorinated elastomeric articles having reduced coefficients of friction, improved wear life and improved resistance to fluid permeability. A thermoplastic elastomeric article is exposed to gaseous fluorine in a reactor vessel under reaction conditions sufficient to create a fluorinated material on the external portions of the elastomeric article, which fluorinated material extends inwardly into the matrix of the article, without promoting degradation of the tensile properties of the article.
Patent DE-69233602-T2 (DE)
Inventor: BONNICHSEN FRITS FRYDENDAL
IPC: A61M5/32
Filed: 1992-07-02
Granted: 2006-12-07
Abstract: An insulin injection system comprises a pen shaped syringe with a cartridge containing insulin, and an injection needle, the needle is a thinner than G 29 needle and the insulin is a type which may freely flow through a thinner than G 29 needle. When the insulin is the type comprising suspended crystals the maximal dimension of any crystal is 15  mu m.
Patent DE-69300148-T2 (DE)
Inventor: MONTECCHI SANTE
IPC: B28B13/02
Filed: 1993-12-30
Granted: 1995-11-02
Abstract: A method for the manufacture of dry-moulded ceramic tiles having effects of veining distributed in the ceramic body, comprises forming a mass of granules or powders with stream tubes flowing distinctly at least in the upper part of said mass, extracting by gravity from the bottom of the mass a layer of powder by means of separate, selected feed-apertures; the plant comprising a hopper (11) containing the powders fed by an alternative distributor (28) having at least two feeding ducts: a grid (10) being slidably mounted below the hopper for feeding the die-matrix (12, 13) by means of a plurality of baffles defining the feed-apertures for the powder. <IMAGE>
Patent DE-69314253-T2 (DE)
Inventor: AKAGI YASABURO
IPC: A61K9/50
Filed: 1993-07-22
Granted: 1998-01-29
Abstract: A novel microparticle preparation comprising microparticles of a polymer which contain a drug and are at least partially or wholly coated with a water-soluble inorganic salt, a water-soluble organic acid or a water-soluble salt of an organic acid, which acts as an agent for preventing aggregation of the microparticle preparation is disclosed. The preparation is produced by spraying a polymer solution containing a drug and a solution or dispersion of a water-soluble inorganic salt, a water-soluble organic acid or a water-soluble salt of an organic acid from different nozzles and contacting them with each other in a spray dryer. In this procedure, if desired, a non-ionic surfactant may be added to the solution of the water-soluble inorganic salt, the water-soluble organic acid or the water-soluble salt of organic acid, or a solution of non-ionic surfactant may be sprayed from the other nozzle simultaneously.
Patent DE-69316064-T2 (DE)
Inventor: RYLEWSKI EUGENIUSZ MICHAL
IPC: E06B9/386
Filed: 1993-03-31
Granted: 1998-04-23
Abstract: The invention relates to a device for collecting solar energy and transferring it to a receiver to be heated. The device comprises a plurality of essentially horizontal profiled elements (16) spaced one from another and superposed to form a curtain having an external face (18) capable of being exposed to solar radiation and an internal face (20) capable of being arranged on the side of the receiver (12), the profiled elements (16) having two reflecting faces and a profile of a shape which is selected so as to define between them a plurality of directed air ducts (28) rising from the external face to the internal face, means of closing (30) being provided on the side of the internal face to immobilise the air contained in the ducts. Application in particular to heating buildings. <IMAGE>
Patent DE-69318859-T2 (DE)
Inventor: MITAL MARC-HENRI
IPC: A61G1/01
Filed: 1993-12-10
Granted: 1999-01-14
Abstract: PCT No. PCT/FR93/01231 Sec. 371 Date Jun. 7, 1995 Sec. 102(e) Date Jun. 7, 1995 PCT Filed Dec. 10, 1993 PCT Pub. No. WO94/13240 PCT Pub. Date Jun. 23, 1994A stretcher comprises an upper sheet and a lower sheet selectively joined together to form a plurality of transverse sleeves. In combination, a plurality of slats having a length greater than the transverse dimension of the sleeves are removably retainable within the transverse sleeves. The slats are provided at their end portions located outside said sleeves with handles to permit transporting of the stretcher. Alternatively, the stretcher comprises a sheet having on one of its surfaces strips (16) of hook and loop type elements, in combination with a plurality of slats that are longer than the width of the sheet. The slats have hook and loop type fasteners adapted to cooperate to removably attach the slats to the hook and loop type fastener strips on the sheet. The said slats have handles at their end portions, spaced from the edges of the sheet, to permit transporting of the stretcher.
Patent DE-69320173-T2 (DE)
Inventor: KLAVENESS JO
IPC: A61B5/053
Filed: 1993-01-04
Granted: 1999-02-04
Abstract: PCT No. PCT/EP93/00006 Sec. 371 Date May 4, 1995 Sec. 102(e) Date May 4, 1995 PCT Filed Jan. 4, 1993 PCT Pub. No. WO93/12717 PCT Pub. Date Jul. 8, 1993Agents for use in improving tissue/tissue contrast in electrical impedance tomography are described. In particular triiodophenyl compounds, metal chelates, magnetic particles, conducting particles and microbubbles may be used.
Patent DE-69327536-T2 (DE)
Inventor: HARTMAN D
IPC: C07D209/10
Filed: 1993-10-12
Granted: 2000-07-06
Abstract: PCT No. PCT/US93/09730 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Oct. 12, 1993 PCT Pub. No. WO94/08962 PCT Pub. Date Apr. 28, 1994Fibrinogen receptor antagonists of the formula:   <IMAGE>   wherein A,B,D,E,Y are as defined in the specification, are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Patent DE-69329497-T2 (DE)
Inventor: BANTZ DAVID
IPC: H04L12/28
Filed: 1993-12-08
Granted: 2001-05-10
Abstract: In a communications system comprising a number of base stations, each base station communicating over a shared communication channel with a plurality of registered stations and controlling the network cell formed by said plurality of registered stations, a method is described for dynamically registering and deregistering mobile stations. Each station owns a unique address and is allocated a local identifier at registration time. Each network cell owns a unique cell identifier known to all registered stations belonging to this network cell. Base stations manage cell members data uniquely associating the unique address and the local identifier corresponding to each one of the mobile stations belonging to their network cell. A registration request is sent to a selected base station by a registering mobile station, comprising the unique cell identifier of the network cell controlled by the selected base station and the unique address of the registering mobile station; the selected base station detects in its cell members data any conflicting registered station whose unique address matches the unique address of the registering mobile station and sends an address check packet to any conflicting registered station, comprising the unique address of the conflicting registered station, its local identifier and the identifier of the network cell it controls. A receiving registered mobile station sends to the selected base station, an acknowledgement to the address check packet if its unique address, the local identifier of its owning base station and its network cell identifier all match with the ones carried by the address check packet. The selected base station rejects the registration request it it receives an acknowledgement to its address check packet. The same address check packet is used to deregister inactive stations. <IMAGE>
Patent DE-69330458-T2 (DE)
Inventor: STADLER MONIKA
IPC: C07K1/18
Filed: 1993-01-20
Granted: 2002-05-29
Abstract: PCT No. PCT/EP93/00114 Sec. 371 Date Aug. 29, 1994 Sec. 102(e) Date Aug. 29, 1994 PCT Filed Jan. 20, 1993 PCT Pub. No. WO93/15105 PCT Pub. Date Aug. 5, 1993Described is an economical process for the recovery of factor VIII from blood plasma or cryoprecipitate. In the process, anion exchanger chromatography is conducted using a separating material based on carriers containing hydroxyl groups, the surfaces of which carriers have been coated with covalently boded polymers. The polymers contain repeating units represented by formula (I).    <IMAGE>
Patent DE-69400266-T2 (DE)
Inventor: GUILLEMANT PHILIPPE
IPC: A61B3/113
Filed: 1994-01-28
Granted: 1997-02-13
Abstract: PCT No. PCT/FR94/00108 Sec. 371 Date Sep. 21, 1994 Sec. 102(e) Date Sep. 21, 1994 PCT Filed Jan. 28, 1994 PCT Pub. No. WO94/16612 PCT Pub. Date Aug. 4, 1994The present invention relates to a process and a device for analyzing the movement of the eye or eyes of a patient, i.e. of a human being or animal. A device comprising a first video camera, a second video camera, which first and second cameras are mounted on a spectacle frame and are rigidly connected together and form part of a removable module; said dirst and second cameras have points of sight of their respective scenes which are close. The technical domain of the invention is that of the manufacture of devices for measuring the movement of the eyes.
Patent DE-69403111-T2 (DE)
Inventor: ALEXANDER ALBERT GORDON
IPC: C10N20/02
Filed: 1994-02-11
Granted: 1997-11-13
Abstract: Solvent-free lubricant compsn. (I) for use in two-cycle internal combustion engines comprises: (a) a major amt. of lubricant oil basestock of kinematic viscosity 1.5-3.0 cSt at 100 deg.C; (b) 3-15 wt.% of a bright stock of kinematic viscosity 20-40 cSt at 100 deg.C; (c) 3-15 wt.% of a polyisobutylene of number average mol.wt. 400-1050; and (d) 3-15 wt.% of a polyisobutylene of number average mol.wt. 1150-1650. (I) has minimum kinematic viscosity 4 cSt at 100 deg.C, maximum kinematic viscosity 12 cSt at 100 deg.C, and flash point greater than 100 deg.C.
Patent DE-69406487-T2 (DE)
Inventor: MAZUREK WILLIAM F
IPC: A61B17/32
Filed: 1994-05-05
Granted: 1998-05-07
Abstract: A rotatable shaver having inner (60) and/or outer (32) non-metallic elongated blades for use in endoscopic surgical procedures. In one embodiment a rotatable, elongated non-metallic inner tubular member (60) is disclosed for use with a non-rotatable elongated metallic outer tubular member (32), the inner member having a flexible, non-metallic tubular body (64), a proximal hub and a distal tip provided with a cutting edge (66). The elongated tubular body (64) of the inner member (60) may be extruded or molded from a polymeric or composite material and may be bonded to or integrally formed with either the hub, the distal cutting tip of both. In one embodiment, the entirety of the rotatable inner tubular member (60, 80) (i.e. hub, tubular body and cutting tip) may be integrally formed as a single unit. In another embodiment, the outer tubular member (82) is formed with a non-metallic tubular sheath within which a metallic or non-metallic inner member (60) may rotate. <IMAGE>
Patent DE-69407146-T2 (DE)
Inventor: SCARLETT JOHN
IPC: C07B61/00
Filed: 1994-01-06
Granted: 1998-04-16
Abstract: Prodn of alcohols and diols by hydrogenation of a corresp. unsatd. organic cpd. selected from esters, diesters and lactones comprises: (a) providing >= 2 hydrogenation zones, each contg a charge of a granular hydrogenation catalyst selected from Cu-contg. and Gp VIII metal-contg catalysts; (b) supplying to>= 1 of the hydrogenation zones, a vapours feed stream comprising a hydrogen-contg. gas and an unsatd. organic cpd. selected from 1-4C alkyl esters of 8-22C alkylcarboxylic acids, di-(1-4C) alkyl diesters of 4-16C dicarboxylic acids, gamma -butyrolactone and epsilon-caprolactone; (c) maintaining the hydrogenation zone at 150-350[deg]C and 150-2000 psia; (d) recovering a reaction prod. stream comprising an alcohol or diol; (e) supplying to >= 1 other hydrogenation zone a stream of hydrogen-contg. gas in order to reactivate the charge of hydrogenation catalyst; (f) supplying to the other hydrogenation zone, in a second phase of operation, a vaporous feed stream comprising a hydrogen-contg gas and the unsatd organic cpd.; (g) maintaining the hydrogenation zone at 150-350[deg]C and 150-200 psia; (h) recovering a reaction prod. stream comprising the alcohol or diol; and (i) supplying, in the second phase of operation, a stream of hydrogen-contg. gas to reactivate the charge of hydrogenation catalyst.
Patent DE-69407783-T2 (DE)
Inventor: BROWN STEPHEN MARTIN
IPC: C07B61/00
Filed: 1994-04-29
Granted: 1998-04-16
Abstract: A process for preparing a compound of formula (I),ed alkyl or phenyl, R2 is COOH, and R3 and R4 are independently selected from hydrogen, halo, haloalkyl, nitro, hydroxy, alkoxy, haloalkoxy or alkoxyalkoxy; which process comprises oxidising a compound of formula (II)    <IMAGE>  (II)  where R1, R3 and R4 are as defined in relation to formula (I) and R5 is H, halo or C1-4 alkyl with sodium hypochlorite or sodium chlorite in the presence of a catalytic amount of a ruthenium or palladium compound and a phase transfer catalyst in an organic solvent at a pH of 7-11.
Patent DE-69412598-T2 (DE)
Inventor: GODEK DENNIS
IPC: C07C41/16
Filed: 1994-01-26
Granted: 1998-12-24
Abstract: A novel two-step reaction process for preparing 5-substituted-2-methoxybenzaldehyde compounds is disclosed wherein the substituent group is either isopropyl or trifluoromethoxy. The process involves (1) reacting a corresponding 4-substituted phenol compound with dimethyl carbonate in the presence of a tertiary-amine base to form the corresponding 4-substituted anisole compound, and (2) thereafter subjecting the latter intermediate product obtained in the first step to aromatic C-formylation on the ring with hexamethylenetetramine in the presence of trifluoroacetic acid, followed by hydrolysis, to ultimately yield the desired aldehyde compound. The two aromatic aldehyde compounds so obtained, viz., 2-methoxy-5-trifluoromethoxybenzaldehyde and 2-methoxy-5-isopropylbenzaldehyde, are known to be useful as intermediates that specifically lead to (2S,3S)-cis-3-(2-methoxy-5-trifluoromethoxybenzyl)amino-2-phenylpiperidine and (2S,3S)-cis-2-(diphenylmethyl)-N-((2-methoxy-5-isopropylphenyl)methyl)-1-azabicyclo(2.2.2)octane-3-amine, respectively. The latter final products, in turn, are both known to be useful in the field of medicinal chemistry as substance P receptor antagonists.
Patent DE-69419394-T2 (DE)
Inventor: MOIREAU PATRICK
IPC: C03C25/26
Filed: 1994-12-06
Granted: 2000-05-18
Abstract: Process for the manufacture of continuous glass filaments. The process consists in depositing on the glass filaments being drawn a size consisting of a solution whose solvent content is lower than 5 % by weight, the said solution including a mixture of components that are polymerisable and/or crosslinkable by heat treatment, the said components being, in the case of at least 60 % by weight thereof, components whose molecular mass is lower than 750, less than 10 % by weight of film-forming agents and from 0 to 25 % by weight of bridging agents, lubricating agents, stabilising agents and initiators and/or catalysts, the said agents being optionally polymerisable and/or crosslinkable by heat treatment, in reeling the filament(s) formed by bringing together the said filaments onto a rotating support to form a winding consisting of turns of filament coated with an unpolymerised size. The filaments are intended for the reinforcement of thermoplastic or heat-curable organic substances or of substances of inorganic origin.
Patent DE-69421418-T2 (DE)
Inventor: CHINH JEAN-CLAUDE
IPC: C08F10/06
Filed: 1994-05-19
Granted: 2000-02-10
Abstract: The invention relates to continuous gas fluidised bed polymerisation of olefins, especially ethylene, propylene, or mixtures of these with other alpha olefins, wherein the monomer-containing recycle gas employed to fluidise the bed is cooled to condense out at least some liquid hydrocarbon. The condensed liquid, which can be a monomer or an inert liquid, is separated from the recycle gas and is introduced directly to the bed to produce cooling by latent heat of evaporation. The liquid is introduced directly into the bed using injection means. The process provides substantially improved productivity of gas fluidised bed polymerisation of olefins. <IMAGE>
Patent DE-69421632-T2 (DE)
Inventor: JACOB JEAN-BAPTISTE
IPC: H04B10/272
Filed: 1994-02-15
Granted: 2000-06-15
Abstract: This satellite centre includes subscriber access circuits (1) produced in electronics technology, which particularly carry out the functions of: translation of the cell headers; addition of a routing label; and policing throughput monitoring. It further includes concentrators (2) including statistical time-division multiplexing devices (34.1, ..., 34.16) and periodic time-division demultiplexing devices (47.1, ..., 47.16) which are produced in electronics technology; and a spectral multiplexing and data rate-changing device (38), a periodic time-division multiplexing device without spectral multiplexing (40), a data rate changing and spectral demultiplexing device (43), and a periodic time-division demultiplexing and spectral multiplexing device (41), which are produced in optical technology. This structure makes it possible to optimise the use of the optical technology and of the electronics technology in order to obtain minimum production costs. Application to asynchronous transfer mode telecommunications networks. <IMAGE>